1
Annette Skinhøj, Poul Bertelsen: Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs). Nycomed Danmark, Peter F Corless, Christine C O&apos Day, Edwards & Angell, July 29, 2003: US06599529 (83 worldwide citation)

An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug substance to obtain both a relatively fast onset of the therapeutic effect and the maintenance of a therapeu ...


2
Annette Skinhoj: Modified release multiple-units dosage composition for release of opioid compounds. Nycomed Danmark, Peter F Dike Bronstein Roberts & Cushman Corless, December 12, 2000: US06159501 (63 worldwide citation)

An oral pharmaceutical modified release multiple-units composition for the administration of an analgesically effective amount of an opoid. The composition comprises at least two fractions wherein individual units containing an opoid are coated with a sustained release coating. A first fraction is a ...


3
Poul Bertelsen, Niels Gjørløv Hansen, Hermann Ruckendorfer, Shigeru Itai: Quick release pharmaceutical compositions of drug substances. Nycomed Danmark, Peter F Corless, Christine C O&apos Day, Edwards & Angell, March 30, 2004: US06713089 (42 worldwide citation)

The present invention relates to an oral modified release pharmaceutical composition for the administration of a therapeutically and/or prophylactically effective amount of an active substance (a drug substance), to obtain a relatively fast or quick onset of the therapeutic and/or prophylactic effec ...


4
Hanne Anette Moesgaard, Karin Lowenstein Christensen: Compositions for treatment of common cold. Nycomed Danmark APS, Wenderoth Lind & Ponack, January 26, 2010: US07652030 (12 worldwide citation)

New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably, the composition comprises ipratropium or a salt thereof in combination with xylometazoline hydrochloride and a salt thereof. Upon topically ...


5

6
Skinhoj Annette, Bertelsen Poul: Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids). Nycomed Danmark, July 12, 2000: EP1017370-A1 (4 worldwide citation)

An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug substance (in the following abbreviated "an NSAID substance") to obtain both a relatively fast or quick onse ...


7
Bønløkke Lisbeth, Christensen Karin Löwenstein, Schlyter Jimmy Hirschsprung, Moesgaard Hanne Anette: (pth) Containing pharmaceutical compositions for oral use. Nycomed Danmark Aps, Bønløkke Lisbeth, Christensen Karin Löwenstein, Schlyter Jimmy Hirschsprung, Moesgaard Hanne Anette, sALBIHNS, January 13, 2005: WO/2005/002549 (3 worldwide citation)

A pharmaceutical composition for oral administration comprising PTH, wherein the in vitro release of PTH-when tested in a dissolution test of pharmacopoeia standard-is delayed with at least 2 hours and once the release starts, at least 90% w/w such as, e.g., at least 95% or at least 99% of all PTH c ...


8
Grarup Jesper, Nielsen Hanne Wulff: Fentanyl composition for nasal administration. Nycomed Danmark Aps, April 5, 2006: EP1642578-A2 (2 worldwide citation)

The treatment of acute pain with a sufficient dosage by intranasal administration of fentanyl results in a time to onset of action comparable to intravenous administration and a significantly faster onset of action than nasal titration of fentanyl. The nasal administration of a sufficient amount of ...


9
Bertelsen Poul, Olsen Peder Mohr: Benzimidazole formulation. Nycomed Danmark Aps, Bertelsen Poul, Olsen Peder Mohr, PLOUGMANN Sundkrogsgade 9 PO Box 831 DK 2100 Copenhagen Ø, October 12, 2006: WO/2006/105798 (2 worldwide citation)

A dry manufacturing process for the production of a pharmaceutical formulation of a benzimidazole and an alkaline substance is described. A tablet is compressed directly from a dry powder or a dry particulate matter avoiding any liquid or excipient conventionally used as a wet binder. The manufactur ...


10
Loer Linderoth Dorte, Lindegaard Hansen Lars: Parathyroid hormone formulations and uses thereof. Nycomed Danmark Aps, Loer Linderoth Dorte, Lindegaard Hansen Lars, WICHMANN Hendrik, April 30, 2009: WO/2009/053106 (2 worldwide citation)

Stable formulations of PTH that may be administered to animal or human subjects are provided herein. In one embodiment, the PTH formulations described herein is in the form of a stable solution formulation comprising PTH, methionine, at least one Poloxamer surfactant, and a physiologically acceptabl ...